Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (420)	4/3/1998 10:31:00 PM
From: bazer	Read Replies (1) \| Respond to of 2887

Jeff, I,m one of those lunkers who bought at 82 cents. Ouch!! Did you happen to see the report on the Monday evening news, ABC I believe, about genetically engineered hormones that are used to grow new blood vessels around blocked arteries? According to the report 12 out of 15 patients benefited from this procedure. One patient had major blockages in his coronary arteries and had repeated angioplasty and open heart procedures and suffered from chest pain. After the hormone treatment he grew arterieos around the blockages and is now pain free. Another patient was going to loss his leg and grew pathways around the blockages and his leg is almost back to normal. They didn't mention any companies, this was university and hospital studies. Sounds like this will take a while to prove itself if it ever does. Is this going to cause a problem for our investment? BAZER